Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Milestone Scientific (MLSS) Common Equity (2016 - 2025)

Historic Common Equity for Milestone Scientific (MLSS) over the last 16 years, with Q3 2025 value amounting to $2.5 million.

  • Milestone Scientific's Common Equity fell 6469.71% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year decrease of 6469.71%. This contributed to the annual value of $5.8 million for FY2024, which is 2720.51% down from last year.
  • Milestone Scientific's Common Equity amounted to $2.5 million in Q3 2025, which was down 6469.71% from $3.3 million recorded in Q2 2025.
  • Over the past 5 years, Milestone Scientific's Common Equity peaked at $19.1 million during Q1 2021, and registered a low of $2.5 million during Q3 2025.
  • Over the past 5 years, Milestone Scientific's median Common Equity value was $8.0 million (recorded in 2023), while the average stood at $10.0 million.
  • Its Common Equity has fluctuated over the past 5 years, first surged by 327145.49% in 2021, then tumbled by 6469.71% in 2025.
  • Quarter analysis of 5 years shows Milestone Scientific's Common Equity stood at $16.4 million in 2021, then tumbled by 37.53% to $10.2 million in 2022, then decreased by 21.64% to $8.0 million in 2023, then decreased by 27.21% to $5.8 million in 2024, then tumbled by 56.29% to $2.5 million in 2025.
  • Its Common Equity stands at $2.5 million for Q3 2025, versus $3.3 million for Q2 2025 and $4.5 million for Q1 2025.